Form 8-K - Current report:
SEC Accession No. 0001193125-22-266779
Filing Date
2022-10-21
Accepted
2022-10-21 16:36:04
Documents
15
Period of Report
2022-10-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d389616d8k.htm   iXBRL 8-K 37350
2 EX-10.1 d389616dex101.htm EX-10.1 1038332
6 GRAPHIC g389616g1020032757807.jpg GRAPHIC 2100
7 GRAPHIC g389616g49p28.gif GRAPHIC 4371
  Complete submission text file 0001193125-22-266779.txt   1433229

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idxx-20221020.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idxx-20221020_lab.xml EX-101.LAB 17238
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idxx-20221020_pre.xml EX-101.PRE 10811
9 EXTRACTED XBRL INSTANCE DOCUMENT d389616d8k_htm.xml XML 3319
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 221324140
SIC: 2835 In Vitro & In Vivo Diagnostic Substances